No Chemo Benefit in Older Women With High-Risk HR-Positive Breast Cancer

(Medage today) – Elderly women with positive breast cancer genomically at high risk (HR) – positive breast cancer did not benefit from adjuvant chemotherapy, which caused a high rate of severe toxicity, according to a large randomized trial. Global survival …